We have recently reported that a single injection of kisspeptin-54 resulted in a luteinizing hormone (LH) surge of ~12–14 h duration, which was sufficient to safely trigger oocyte maturation in women at high risk of OHSS (Abbara et al., 2015). Here, KISS1 is linked to ovarian hyperstimulation syndrome.